Published in
Elsevier, The Lancet Oncology, 2(22), p. 277-288, 2021
DOI: 10.1016/s1470-2045(20)30591-x
Links
Tools
Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial
Journal article published in 2020 by
Robert D. Morgan,
Iain A. McNeish,
Adrian D. Cook,
Elizabeth C. James 
,
Rosemary Lord,
Graham Dark,
Rosalind M. Glasspool,
Jonathan Krell,
Christine Parkinson,
Christopher J. Poole,
Marcia Hall,
Dolores Gallardo-Rincón,
Michelle Lockley,
Sharadah Essapen,
Jeff Summers
and other authors.
,
Rosemary Lord,
Graham Dark,
Rosalind M. Glasspool,
Jonathan Krell,
Christine Parkinson,
Christopher J. Poole,
Marcia Hall,
Dolores Gallardo-Rincón,
Michelle Lockley,
Sharadah Essapen,
Jeff Summers
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 